Clinical Trial Update: Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 clinical trial evaluating universal CAR-T cells REVO-UWD-01 for colorectal cancer, including metastatic disease, is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• REVO-UWD-01

Snippet

Sponsor: Wondercel Biotech (ShenZhen) | Conditions: CRC (Colorectal Cancer), Metastatic Colorectal Cancer | EARLY_Phase 1 | Status: RECRUITING